First copies of gilead virus drug to start selling in Bangladesh
![]() 2629 Thursday, 21 May, 2020, 15:45 Bangladesh’s Beximco Pharmaceuticals Ltd. said it has become the world’s first company to start selling the generic version of Gilead Sciences Inc.’s antiviral drug on mounting urgency to treat the infection caused by the deadly coronavirus across the developing world. The Dhaka-based Beximco, which counts Norges Bank as one of its investors, will sell remdesivir for about 6,000 taka ($71) a vial to private clinics but will give it free to state-run hospitals treating Covid-19 patients, Rabbur Reza, chief operating officer at the company, said in an interview. A critically ill Covid-19 patient will need at least six vials, he said. |
Kenya's refugee camps suffer as US slashes aid (video)
290711.08.2025, 23:36US considering China travel warning after nearly 5,000 cases of deadly virus: report
408503.08.2025, 18:12Armenian doctor helps 14-year-old girl give birth during earthquake
363130.07.2025, 16:00Doctors in Kamchatka continued surgery during earthquake (video)
376730.07.2025, 10:44Trump says Coca-Cola agreed to use real cane sugar in US
456617.07.2025, 09:48White House doctor says Trump is 'fully fit' in medical report
1027213.04.2025, 23:03Chinese team finds new bat coronavirus that could infect humans
1174221.02.2025, 11:20"Don't lose hope if you struggle with acne," advises Dr. Maria Novosartyan (photo)
630009.01.2025, 22:06